MRC to go ahead with controversial tamoxifen trial.
D030881:Disclosure; D005260:Female; D006805:Human Experimentation; D006801:Humans; D009369:Neoplasms; D004364:Pharmaceutical Preparations; D010919:Placebos; D011315:Preventive Medicine; D011897:Random Allocation; D012106:Research; D012107:Research Design; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation; D006113:United Kingdom; D014930:Women
Biomedical and Behavioral Research; Medical Research Council (Great Britain)